Otilia Kimpel

Wuerzburg, BY 97080, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications

Does Automated Versus Manual Ki67 Labeling Index Assessment Influence Risk Stratification in Patients with Localized Adrenocortical Carcinoma? Lessons from the ADIUVO Trial.

Does Automated Versus Manual Ki67 Labeling Index Assessment Influence Risk Stratification in Patients with Localized Adrenocortical Carcinoma? Lessons from the ADIUVO Trial.

Journal: Cancers
Published: July 06, 2026

Impact of Neuroendocrine Neoplasm-Specific Systemic Treatments on Somatostatin Receptors Expression and Function in Neuroendocrine Tumor Cells.

Impact of Neuroendocrine Neoplasm-Specific Systemic Treatments on Somatostatin Receptors Expression and Function in Neuroendocrine Tumor Cells.

Journal: Cancers
Published: March 19, 2026

Baseline biochemical evaluation for etiologic differentiation in ACTH-dependent Cushing's syndrome: machine learning and composite score analysis in a multicenter cohort of 566 patients.

Baseline biochemical evaluation for etiologic differentiation in ACTH-dependent Cushing's syndrome: machine learning and composite score analysis in a multicenter cohort of 566 patients.

Journal: European journal of endocrinology
Published: December 07, 2025

Clinical predictors of outcome in advanced adrenocortical carcinoma: a multicenter international ENSAT study.

Clinical predictors of outcome in advanced adrenocortical carcinoma: a multicenter international ENSAT study.

Journal: European journal of endocrinology
Published: November 06, 2025

Current clinical management and outcome of patients with adrenal cortical carcinoma (ACC) with rare histological subtypes-an ENSAT cohort study.

Current clinical management and outcome of patients with adrenal cortical carcinoma (ACC) with rare histological subtypes-an ENSAT cohort study.

Journal: ESMO open
Published: September 27, 2025

Psychosocial burden in adrenocortical carcinoma patients.

Psychosocial burden in adrenocortical carcinoma patients.

Journal: European journal of endocrinology
Published: September 22, 2025

Quality of life in patients with pheochromocytoma and paraganglioma: influence of tumor type, genetics and surgical resection.

Quality of life in patients with pheochromocytoma and paraganglioma: influence of tumor type, genetics and surgical resection.

Journal: European journal of endocrinology
Published: August 25, 2025

Mismatch repair deficiency and microsatellite instability in adrenocortical carcinoma.

Mismatch repair deficiency and microsatellite instability in adrenocortical carcinoma.

Journal: ESMO open
Published: July 22, 2025

Agouti-related peptide: a promising prognostic biomarker in adrenocortical carcinoma. Results from a large single-centre cross-sectional analysis.

Agouti-related peptide: a promising prognostic biomarker in adrenocortical carcinoma. Results from a large single-centre cross-sectional analysis.

Journal: European journal of endocrinology
Published: June 29, 2025

Metabolic phenotype in non-aldosterone producing adrenal adenomas with co-existent polycystic ovary syndrome: a joint Ens@t project.

Metabolic phenotype in non-aldosterone producing adrenal adenomas with co-existent polycystic ovary syndrome: a joint Ens@t project.

Journal: Endocrine
Published: May 06, 2025

Mitotane treatment of adrenocortical carcinoma induces tumoural secretion of GDF-15: impact on poor prognosis and impaired responsiveness to immunotherapy.

Mitotane treatment of adrenocortical carcinoma induces tumoural secretion of GDF-15: impact on poor prognosis and impaired responsiveness to immunotherapy.

Journal: European journal of endocrinology
Published: November 25, 2024

Emerging role of IGF1R and IR expression and localisation in adrenocortical carcinomas.

Emerging role of IGF1R and IR expression and localisation in adrenocortical carcinomas.

Journal: Cell communication and signaling : CCS
Published: October 08, 2024
Showing 1-12 of 29

Last Updated: 09/26/2026